12-Oct-2026Today's Market Indicators


Jubilant Pharmova seeks to raise Rs 800 crore via private placement of NCDs
(13:23, 12 Oct 2026)

Jubilant Pharmova Limited announced the board’s approval to raise up to Rs 800 crore through the issuance of up to 80,000 fully paid-up, rupee-denominated, secured/unsecured, listed, rated, redeemable non-convertible debentures (NCDs) with a face value of Rs 1,00,000 each, on a private placement basis, potentially in multiple tranches, subject to regulatory approvals. Additionally, the company seeks shareholder authorization via a special resolution through postal ballot to issue non-convertible debt securities on a private placement basis for an aggregate amount not exceeding Rs 2,500 crore over a one-year period. The NCDs are planned to be listed on the Bombay Stock Exchange (BSE), with a tenure of up to five years and coupon/interest rates to be determined through a bidding process.